Skip to main content
Livermore
Livermore
ZHEN

Aptus Capital Advisors, LLC

SEC CIK
0001664193
Latest filing
Aug 12, 2026

TMO holding history

Thermo Fisher Scientific Inc. in every 13F filed by Aptus Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMO overviewAll 13F holders of TMOFull Q2 2026 holdings

Shares (Q2 2026)
47,091
Value
$23.6M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of TMO by Aptus Capital Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202647,091$23.6M0.2%+851+1.8%AddedHolders
Q1 202646,240$22.7M0.2%−11,704−20.2%ReducedHolders
Q4 202557,944$33.6M0.3%+1,757+3.1%AddedHolders
Q3 202556,187$27.3M0.2%+44,485+380.1%AddedHolders
Q2 202511,702$4.74M<0.1%+3,031+35.0%AddedHolders
Q1 20258,671$4.31M<0.1%−34,309−79.8%ReducedHolders
Q4 202442,980$22.4M0.3%+5,215+13.8%AddedHolders
Q3 202437,765$23.4M0.4%+5,996+18.9%AddedHolders
Q2 202431,769$17.6M0.3%+6,695+26.7%AddedHolders
Q1 202425,074$14.6M0.3%+2,607+11.6%AddedHolders
Q4 202322,467$11.9M0.4%+34+0.2%AddedHolders
Q3 202322,433$11.4M0.3%−988−4.2%ReducedHolders
Q2 202323,421$12.2M0.4%−1,234−5.0%ReducedHolders
Q1 202324,655$14.2M0.4%+1,709+7.4%AddedHolders
Q4 202222,946$12.6M0.4%−1,587−6.5%ReducedHolders
Q3 202224,533$12.4M0.4%+1,624+7.1%AddedHolders
Q2 202222,909$12.4M0.4%−16−0.1%ReducedHolders
Q1 202222,925$13.5M0.4%+3,033+15.2%AddedHolders
Q4 202119,892$13.3M0.5%+3,009+17.8%AddedHolders
Q3 202116,883$9.65M0.4%+4,049+31.5%AddedHolders
Q2 202112,834$6.47M0.3%+6,117+91.1%AddedHolders
Q1 20216,717$3.06M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.